052670 — Cheil Bio Co Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,043 | 994 | -712 | -1,708 | -1,446 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -852 | 1,852 | 2,275 | 568 | -557 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3,434 | -5,507 | -2,147 | 8,606 | -2,251 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 5,018 | -2,297 | -104 | 7,729 | -4,072 |
Capital Expenditures | -13.8 | -13.9 | -65 | -11.5 | -214 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -643 | 4,628 | -7,715 | 6,897 | -1,569 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -657 | 4,614 | -7,780 | 6,885 | -1,783 |
Financing Cash Flow Items | — | — | — | -40 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -58.6 | 6,382 | -41.8 | -3,083 | -39.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4,311 | 8,491 | -7,890 | 11,515 | -5,896 |